HAWRYLUK P. KENT (President & CEO) purchased 4.0% of their position (18.50K shares) of MBX BIOSCIENCES, INC. on the open market
Open‑market purchase worth $525.7K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/16/2026ACC: 0001193125-26-107268
DirectorOfficer· President & CEO
Since Feb 2026
+18.50K
Net shares
Net buyer
$525.7K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
18.50K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+18.50K
Price / share
$28.41
Trade value
$525.66K
% of position
4.0%
3/13/2026
468.28K→486.78K
Total
Net shares
+18.50K
Net value
$525.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/13/2026 | P · Purchase | +18.50K | $28.41 | $525.66K | 4.0% | 468.28K | 486.78K |
| Total | +18.50K | $525.66K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned728.27K
Total
728.27K direct728.27K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 728.27K | Direct |
| Total | 728.27K | 728.27K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported